In a study of 48–52-year-old male hepatocellular carcinoma patients diagnosed with chronic hepatitis B, PARP4 variants were detected in > 10% of the whole-genome sequencing samples, with functional inhibitions of DNA BER and tumor cell apoptosis in vivo [36]. The gene discussed is PARP4; the disease is hepatocellular carcinoma.